Your browser doesn't support javascript.
loading
[Retracted] MicroRNA­599 targets high­mobility group AT­hook 2 to inhibit cell proliferation and invasion in clear cell renal carcinoma.
Zhao, Hailing; Zhao, Huizhen; Xia, Xiaolin; Liu, Xiujuan.
Afiliación
  • Zhao H; Department of Pediatrics, Yidu Central Hospital of Weifang, Weifang, Shandong 262550, P.R. China.
  • Zhao H; Department of Pediatrics, Yidu Central Hospital of Weifang, Weifang, Shandong 262550, P.R. China.
  • Xia X; Department of Pediatrics, Yidu Central Hospital of Weifang, Weifang, Shandong 262550, P.R. China.
  • Liu X; Department of Nephrology, Weifang People's Hospital, Weifang, Shandong 261000, P.R. China.
Mol Med Rep ; 28(2)2023 Aug.
Article en En | MEDLINE | ID: mdl-37387414
ABSTRACT
Following the publication of the above paper, it was drawn to the Editors' attention by a concerned reader that cell migration and invasion assay data shown in Fig. 5C were strikingly similar to data appearing in different form in other articles by different authors, which have been retracted. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, elsewhere when it was submitted to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive any reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 17 7451­7459, 2018; DOI 10.3892/mmr.2018.8755].
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Med Rep Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Mol Med Rep Año: 2023 Tipo del documento: Article